找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Nachhaltigkeit erm?glichen; Vom Buzzword zur gel Sabrina Krauss,Philipp Plugmann Book 2024 Der/die Herausgeber bzw. der/die Autor(en), exkl

[復(fù)制鏈接]
樓主: OBESE
31#
發(fā)表于 2025-3-27 00:08:59 | 只看該作者
32#
發(fā)表于 2025-3-27 03:48:58 | 只看該作者
33#
發(fā)表于 2025-3-27 08:00:56 | 只看該作者
34#
發(fā)表于 2025-3-27 12:21:05 | 只看該作者
35#
發(fā)表于 2025-3-27 17:07:20 | 只看該作者
36#
發(fā)表于 2025-3-27 20:56:02 | 只看該作者
Sabrina Krausss can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical com
37#
發(fā)表于 2025-3-27 23:07:36 | 只看該作者
Julia Plugmann,Philipp Plugmanns can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical com
38#
發(fā)表于 2025-3-28 04:26:46 | 只看該作者
Arno Lammertss can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical com
39#
發(fā)表于 2025-3-28 06:33:28 | 只看該作者
40#
發(fā)表于 2025-3-28 12:20:05 | 只看該作者
Andreas Kirstas well as how one defines a dose response relationship using intravenous critical care medicines were discussed as important clinical trial issues. The benefit versus risk data on currently available thrombolytic agents was reviewed and the potential roles for adjunctive agents addressed. Overall s
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 09:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
肥乡县| 汕尾市| 乐陵市| 盐城市| 碌曲县| 海城市| 肇东市| 紫金县| 洱源县| 陇西县| 万源市| 武陟县| 临猗县| 苍山县| 五大连池市| 嵩明县| 乐山市| 米易县| 大石桥市| 汤阴县| 淳化县| 缙云县| 资阳市| 德令哈市| 德庆县| 米泉市| 梓潼县| 西林县| 科尔| 马龙县| 政和县| 东乡县| 平果县| 秦皇岛市| 石门县| 陇南市| 南澳县| 梁平县| 喀喇沁旗| 麻栗坡县| 遵义县|